ArticleImmunologic research2025
Predictive value of serum lipid for kawasaki disease shock syndrome: a prospective study.
Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Background Kawasaki disease shock syndrome (KDSS) is a severe form of Kawasaki disease (KD). The serum lipid has been proposed to be valuable in predicting shock syndrome in clinical circumstances; however, limited data is available in KDSS patients. Therefore, we prospectively evaluated the ability of serum lipid in predicting KDSS. Methods A total of 1009 KD patients aged 2 months to 139 months were enrolled in this prospective cohort study between June 2017 and April 2022. The demographic/clinical characteristics and laboratory data were compared between the patients with KDSS (KDSS group) and those without (KD group). Multivariate logistic regression analysis was utilized to determine the correlation between serum lipid and KDSS. Receiver operating characteristic (ROC) curve analysis was subsequently performed to assess the validity of serum lipids in predicting KDSS. Results Except for triglyceride (TG), almost all the levels of detected lipid profiles were significantly lower in the KDSS subjects compared to non-KDSS patients. In terms of KDSS prediction, the cut-off values of 2.845 mmol/L, 0.355 mmol/L, 1.405 mmol/L, 0.595 g/L, and 0.805 g/L for total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A (Apo A) and apolipoprotein B (Apo B), yielded sensitivities of 80%, 68%, 64%, 76% and 88%, with specificities of 69%, 93%, 89%, 83% and 51%, respectively. Conclusions Lipid profiles were robustly dysregulated in KDSS patients. Noticeably, serum lipid was a complementary laboratory marker for KDSS prediction.
Indexed as
Identifiers
41428125What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.